TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31972065

Group type: EXPERIMENTAL
Intervention: Lidocaine
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Mepivacaine
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Perineural anaesthesia (positive control)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Saline (negative control)
Number of subjects: 6
Study: 31418143

Group type: EXPERIMENTAL
Intervention: Continuous intravenous Molsidomine plus intraventricular sodium nitroprusside (SNP) boluses after TCD-confirmed macrospasm.
Number of subjects: 18
Study: 29439147

Group type: EXPERIMENTAL
Intervention: IONIS-PTP-1BRx 200 mg once weekly for 26 weeks
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study: 27587286

Group type: EXPERIMENTAL
Intervention: Nap condition
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: No-nap condition
Number of subjects: 60

Group type: COMPARATOR
Intervention: Baseline control condition
Number of subjects: 60
Study: 24673467

Group type: EXPERIMENTAL
Intervention: Partial removable dental prosthesis (PRDP) with precision attachments
Number of subjects: 105

Group type: COMPARATOR
Intervention: SDA concept aiming at pre-molar occlusion
Number of subjects: 105
Study: 22764294

Group type: EXPERIMENTAL
Intervention: Interferon-γ (IFN-γ) response using Quantiferon-Leishmania assay against three Leishmania peptide antigens
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Leishmanin skin test (LST)
Number of subjects: 352
Study: 19695841

Group type: EXPERIMENTAL
Intervention: Acute Citalopram administration
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Chronic Citalopram administration
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 17337504

Group type: EXPERIMENTAL
Intervention: Motivational interviewing
Number of subjects: 217

Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 217
Study: 15762966

Group type: EXPERIMENTAL
Intervention: Foley catheter
Number of subjects: 100

Group type: COMPARATOR
Intervention: PGE2 gel
Number of subjects: 100
Study: 12166504

Group type: EXPERIMENTAL
Intervention: High-dose intravenous corticosteroids
Number of subjects: 383
Study: 10514351

Group type: EXPERIMENTAL
Intervention: MCP plus hydrocortisone (HC) delivered via transdermal iontophoresis (IP) at a constant current of 100 microA/cm(2) for 4 hours.
Number of subjects: 7

Group type: COMPARATOR
Intervention: MCP alone delivered via transdermal iontophoresis (IP) at a constant current of 100 microA/cm(2) for 4 hours.
Number of subjects: 7
Study: 8598936

Group type: EXPERIMENTAL
Intervention: Autologous cytokine mobilised blood cells (BC)
Number of subjects: 69
Study: 1901418

Group type: EXPERIMENTAL
Intervention: Fluvoxamine (100‐300 mg/d)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Maprotiline (50‐150 mg/d)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Maprotiline
Number of subjects: 48
Study: 7167401

Group type: EXPERIMENTAL
Intervention: 120 ng/kg/hr ceruletide IV
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 60 ng/kg/hr ceruletide IV
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 6 ng/kg/hr ceruletide IV
Number of subjects: 24

Group type: COMPARATOR
Intervention: 0.4 mg/kg/hr pentazocine IV
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: naloxone
Number of subjects: 24
Study: 30243425

Group type: EXPERIMENTAL
Intervention: Hatha yoga intervention (12 sessions, 90 minutes each)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 73
Study: 28150855

Group type: EXPERIMENTAL
Intervention: Oral contraceptives
Number of subjects: 70
Study: 25794868

Group type: EXPERIMENTAL
Intervention: Nordic hamstring exercise (NHE), performed 25 sessions over 13 weeks.
Number of subjects: 579

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned), regular soccer training only.
Number of subjects: 579

Group type: COMPARATOR
Intervention: NHE intervention group vs control group.
Number of subjects: 579

Group type: EXPERIMENTAL
Intervention: NHE intervention compliance.
Number of subjects: 579
Study: 23727419

Group type: EXPERIMENTAL
Intervention: 2-day-soluble gelatin sponge particles (2DS-GSPs)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Lipiodol plus insoluble gelatin sponge particles (Gelpart)
Number of subjects: 73
Study: 20573679

Group type: EXPERIMENTAL
Intervention: Ultra-conservative surgical approach (bilateral cystectomy)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Less conservative surgery (oophorectomy plus controlateral cystectomy)
Number of subjects: 32
Study: 18407027

Group type: EXPERIMENTAL
Intervention: Fluoride varnish applied to test teeth
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group (no fluoride varnish)
Number of subjects: 15
Study: 16637075

Group type: EXPERIMENTAL
Intervention: 240 mg of clover phytoestrogens daily for 2 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 15621100

Group type: EXPERIMENTAL
Intervention: Brachiocephalic loop PTFE fistula (Group 1)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Brachioaxillary PTFE fistula (Group 2)
Number of subjects: 46
Study: 10921536

Group type: EXPERIMENTAL
Intervention: Zinc sulfate supplementation (7.7 pmol, 2200 microg daily for 90 days)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Zinc sulfate supplementation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Cornstarch placebo capsule
Number of subjects: 20
Study: 9150334

Group type: EXPERIMENTAL
Intervention: Glass syringe stored in ice-water (IW)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Plastic syringe at room temperature (RT)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Glass syringe at room temperature (RT)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Plastic syringe stored in ice-water (IW)
Number of subjects: 10

Group type: COMPARATOR
Intervention: All other methods (plastic and glass syringes)
Number of subjects: 10
Study: 8265163

Group type: EXPERIMENTAL
Intervention: Lid-rubbing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-invasive tear break-up time (NITBUT) measurement after lid raising
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fluorescein application with lid raised or not raised
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TBUT measurement with lid raised (not in contact with cornea)
Number of subjects: 0
Study: 2858215

Group type: EXPERIMENTAL
Intervention: Fenoldopam (100 mg)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 3071032

Group type: EXPERIMENTAL
Intervention: diclofenac 50 mg plus B vitamins (B1, B6, B12)
Number of subjects: 238

Group type: COMPARATOR
Intervention: diclofenac 50 mg
Number of subjects: 238
Study: 29895309

Group type: EXPERIMENTAL
Intervention: Very high intact-protein formula (VHPF) (8 g/100 kcal)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Standard high protein formula (SHPF) (5 g/100 kcal)
Number of subjects: 44
Study: 27133918

Group type: EXPERIMENTAL
Intervention: Cervical cancer screening with overdiagnosis information
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Cervical cancer screening without overdiagnosis information
Number of subjects: 168

Group type: COMPARATOR
Intervention: Non-cancer screening test
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Cervical cancer screening
Number of subjects: 168
Study: 24361112

Group type: EXPERIMENTAL
Intervention: Levodopa-carbidopa intestinal gel infusion
Number of subjects: 66

Group type: COMPARATOR
Intervention: Immediate-release oral levodopa-carbidopa
Number of subjects: 66
Study: 23020995

Group type: EXPERIMENTAL
Intervention: Pindolol
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Labetalol
Number of subjects: 20
Study: 20141455

Group type: EXPERIMENTAL
Intervention: Teaching session on nicotine addiction (two short talks added to the standard course)
Number of subjects: 322

Group type: COMPARATOR
Intervention: Standard smoking cessation course
Number of subjects: 322
Study: 19068597

Group type: EXPERIMENTAL
Intervention: Expansion of ulnar nerve groove and interfascicular neurolysis under microscope
Number of subjects: 22

Group type: COMPARATOR
Intervention: Forward moving of ulnar nerve and interfascicular neurolysis under microscope
Number of subjects: 22
Study: 16099632

Group type: EXPERIMENTAL
Intervention: Methotrexate 10mg once weekly for a year
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Methotrexate
Number of subjects: 46
Study: 14648210

Group type: EXPERIMENTAL
Intervention: CHOP regimen (doxorubicin 50 mg/m2, cyclophosphamide 750 mg/m2, vincristine 1.4 mg/m2, prednisolone 100 mg/body)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: THP-COP regimen (pirarubicin 50 mg/m2, cyclophosphamide 750 mg/m2, vincristine 1.4 mg/m2, prednisolone 100 mg/body)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Both regimens
Number of subjects: 80
Study: 10986304

Group type: EXPERIMENTAL
Intervention: Shared care system (patient- or GP-initiated hospital review)
Number of subjects: 209

Group type: COMPARATOR
Intervention: Rheumatologist-initiated medical review (control)
Number of subjects: 209
Study: 9329344

Group type: EXPERIMENTAL
Intervention: Dexamethasone (total dose, 10 mg/4 days)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 8175269

Group type: EXPERIMENTAL
Intervention: Electrified drain (ED)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conventional drain (CD)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 24
Study: 3948478

Group type: EXPERIMENTAL
Intervention: High dietary carbohydrate (CHO) intake
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Dieting (regardless of CHO content)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: T3 administration (30‐80 micrograms/day)
Number of subjects: 8
Study: 29745626

Group type: EXPERIMENTAL
Intervention: Mentally-performed deep cervical flexor exercises
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Mentally-performed superficial neck flexor exercises
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Actively performed superficial neck flexor exercises
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Actively performed deep cervical flexor exercises
Number of subjects: 16

Group type: COMPARATOR
Intervention: Actively performed deep cervical neck flexor exercises
Number of subjects: 16

Group type: COMPARATOR
Intervention: Mentally performed deep cervical neck flexor exercises
Number of subjects: 16
Study: 29484149

Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 30
Study: 26201750

Group type: EXPERIMENTAL
Intervention: Booklet only (Group A)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Booklet with answers to clarification questions (Group B)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Routine care (Group C)
Number of subjects: 105
Study: 23744045

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy for insomnia (CBT-I)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Sleep hygiene (SH) education program
Number of subjects: 64
Study: 22998978

Group type: EXPERIMENTAL
Intervention: Nutraceutical pill containing berberine (BBR)
Number of subjects: 258

Group type: COMPARATOR
Intervention: Ezetimibe (EZE)
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: Combined treatment with BBR and EZE
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: Addition of BBR in HeFH patients
Number of subjects: 258
Study: 19194996

Group type: EXPERIMENTAL
Intervention: Expressive writing intervention (20 min writing for four consecutive days)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control group (normal care)
Number of subjects: 93
Study: 18624109

Group type: EXPERIMENTAL
Intervention: Optoelectronic method (Truscreen)
Number of subjects: 147
Study: 16005929

Group type: EXPERIMENTAL
Intervention: Motion coherence task
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Biological motion task
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 2-D form-from-motion task
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 0
Study: 12412864

Group type: COMPARATOR
Intervention: Oxygen-driven nebulizer (ODN)
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Home-made non-valved spacer (NVS)
Number of subjects: 196
Study: 10954008

Group type: EXPERIMENTAL
Intervention: Chlorthalidone (with the addition of atenolol or reserpine if needed)
Number of subjects: 4327

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4327
Study: 9411420

Group type: EXPERIMENTAL
Intervention: Endogenous TNF alpha serum concentration monitoring
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (healthy persons)
Number of subjects: 27
Study: 1489769

Group type: EXPERIMENTAL
Intervention: Isotoner compression gloves
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Futuro compression gloves
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 39
Study: 2951178

Group type: EXPERIMENTAL
Intervention: porcine soluble and isophane, premixed porcine soluble/isophane, porcine soluble and lente, bovine ultralente with three porcine soluble injections before meals (all taken twice daily, and once daily for bovine ultralente)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: premixed insulins
Number of subjects: 12

Group type: COMPARATOR
Intervention: various insulin regimens
Number of subjects: 12
Study: 31810744

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 418

Group type: EXPERIMENTAL
Intervention: Fludrocortisone
Number of subjects: 418

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 418
Study: 30760277

Group type: EXPERIMENTAL
Intervention: alteplase-dose arm of the ENCHANTED trial (HSRCs)
Number of subjects: 774
Study: 28376980

Group type: EXPERIMENTAL
Intervention: Vignette with white child
Number of subjects: 342

Group type: COMPARATOR
Intervention: Vignette with black child
Number of subjects: 342
Study: 25595117

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 200 mg tid
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 22251431

Group type: EXPERIMENTAL
Intervention: In-group authority administering non-instrumental voice
Number of subjects: 0

Group type: COMPARATOR
Intervention: Out-group authority administering non-instrumental voice
Number of subjects: 0
Study: 21736814

Group type: EXPERIMENTAL
Intervention: Polydextrose (PDX) 21 g/d
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Soluble maize fibre (SCF) 21 g/d
Number of subjects: 21

Group type: COMPARATOR
Intervention: No fibre control (NFC)
Number of subjects: 21
Study: 19794266

Group type: EXPERIMENTAL
Intervention: Metronidazole 500 mg b.i.d, amoxicillin 1g b.i.d, omeprazole 20 mg b.i.d, bismuth 240 mg b.i.d (MAO-B group)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Azithromycin 500 mg once daily for 1 week, amoxicillin 1g b.i.d, omeprazole 20 mg b.i.d, bismuth 240 mg b.i.d for 2 weeks (AAO-B group)
Number of subjects: 60
Study: 16333556

Group type: EXPERIMENTAL
Intervention: Alvimopan 6 mg
Number of subjects: 615

Group type: EXPERIMENTAL
Intervention: Alvimopan 12 mg
Number of subjects: 615

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 615
Study: 14738417

Group type: EXPERIMENTAL
Intervention: Sulthiame (STM)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 11050374

Group type: EXPERIMENTAL
Intervention: 5.8% hypertonic saline infusion
Number of subjects: 36

Group type: COMPARATOR
Intervention: 0.9% isotonic saline infusion (control)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 5.8% saline infusion with feedback from the right masseter sEMG
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 5.8% saline infusion with both sEMG and imEMG recorded
Number of subjects: 36
Study: 9152116

Group type: EXPERIMENTAL
Intervention: Tiagabine 16 mg 2 times per day
Number of subjects: 351

Group type: EXPERIMENTAL
Intervention: Tiagabine 8 mg 4 times daily
Number of subjects: 351

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 351
Study: 8423882

Group type: EXPERIMENTAL
Intervention: Botulinum-A toxin (BTX-A) injections
Number of subjects: 20

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 20
Study: 3622203

Group type: EXPERIMENTAL
Intervention: Subcutaneous insulin infusion
Number of subjects: 5

Group type: COMPARATOR
Intervention: Intravenous insulin infusion
Number of subjects: 5
Study: 29338111

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (12 weeks, twice-weekly)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Usual care without scheduled physical exercise
Number of subjects: 53
Study: 27650928

Group type: EXPERIMENTAL
Intervention: Infant formula enriched by functional ingredients (n = 24)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard formula (n = 25)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Exclusively breast-fed (n = 11)
Number of subjects: 60
Study: 26584856

Group type: EXPERIMENTAL
Intervention: Sit-stand workstation
Number of subjects: 47
Study: 23680075

Group type: EXPERIMENTAL
Intervention: Extended VBRT (36 weeks)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Standard VBRT (12 weeks)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 130
Study: 21210170

Group type: EXPERIMENTAL
Intervention: Gentian violet (GV) 0.00165%
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Gentian violet (GV) 0.1%
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Gentian violet (GV) 0.0085%
Number of subjects: 15
Study: 18086028

Group type: EXPERIMENTAL
Intervention: PQI adhesive system
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: OptiBond Solo Plus adhesive system
Number of subjects: 60
Study: 16941631

Group type: EXPERIMENTAL
Intervention: Caffeine (100 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chlorpheniramine (4 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no vasomodulator)
Number of subjects: 0
Study: 12865903

Group type: EXPERIMENTAL
Intervention: Magnetic seizure therapy (MST)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Electroconvulsive therapy (ECT)
Number of subjects: 10
Study: 10863253

Group type: EXPERIMENTAL
Intervention: Lumbar posteroanterior mobilization
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 26
Study: 10423616

Group type: EXPERIMENTAL
Intervention: Diclofenac potassium (25 mg)
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Diclofenac potassium (50 mg)
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Diclofenac potassium (100 mg)
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Aspirin (650 mg)
Number of subjects: 255

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 255
Study: 7862904

Group type: EXPERIMENTAL
Intervention: Nefazodone (100-400 mg/day)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Amitriptyline (50-200 mg/day)
Number of subjects: 106
Study: 2678877

Group type: EXPERIMENTAL
Intervention: Fentanyl TTS (transdermal drug delivery system, delivery rate of 75 micrograms/hour)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 766800

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide continuously
Number of subjects: 99

Group type: COMPARATOR
Intervention: Combination of cyclophosphamide, methotrexate, 5-fluorouracil and vinblastine given intermittently
Number of subjects: 99
Study: 31089777

Group type: EXPERIMENTAL
Intervention: Surgical treatment with a newly introduced technique (annular closure device) during standard operation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard surgical treatment without the annular closure device
Number of subjects: 0
Study: 31238908

Group type: EXPERIMENTAL
Intervention: Tablet-based training programme during and for 9 months after the MKP
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 0
Study: 28470676

Group type: EXPERIMENTAL
Intervention: NDI‐010976 (20 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NDI‐010976 (50 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NDI‐010976 (200 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 26385134

Group type: EXPERIMENTAL
Intervention: Cold gel pack (3-5 °C)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Room-temperature gel pack (20 °C)
Number of subjects: 35
Study: 25004184

Group type: EXPERIMENTAL
Intervention: Citalopram as adjunctive therapy to risperidone and olanzapine
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Reboxetine as adjunctive therapy to risperidone and olanzapine
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 22798534

Group type: EXPERIMENTAL
Intervention: IV dexamethasone 0.5 mg/kg
Number of subjects: 160

Group type: COMPARATOR
Intervention: IV methylprednisolone 2.5 mg/kg
Number of subjects: 160
Study: 19650710

Group type: EXPERIMENTAL
Intervention: Intravitreal 0.2 mL autologous plasmin enzyme (APE) injection
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control eye (no injection)
Number of subjects: 16
Study: 17893531

Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Amniotic membrane transplantation (AMT)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Autologous limbal transplantation (ALT)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: ALT + AMT
Number of subjects: 12
Study: 14754695

Group type: EXPERIMENTAL
Intervention: Weekly courses of betamethasone
Number of subjects: 161

Group type: COMPARATOR
Intervention: Single course of betamethasone
Number of subjects: 161
Study: 12139812

Group type: EXPERIMENTAL
Intervention: Limbal epithelial autograft transplantation (A group)
Number of subjects: 208

Group type: COMPARATOR
Intervention: Simple pterygium excision (B group)
Number of subjects: 208
Study: 10186934

Group type: EXPERIMENTAL
Intervention: Worksite intervention program focusing on social cognitive theory constructs, including self-regulation techniques and outcome-expectancy value.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison group received a program of assessment, instruction, and access to facilities common in worksite fitness promotion programs.
Number of subjects: 0
Study: 7561987

Group type: EXPERIMENTAL
Intervention: Parent-reported measures of ETS exposure
Number of subjects: 91
Study: 2048574

Group type: EXPERIMENTAL
Intervention: Erythropoietin therapy
Number of subjects: 118

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 118
Study: 6171080

Group type: EXPERIMENTAL
Intervention: Intensive policy (I)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Routine policy (R)
Number of subjects: 150